These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

318 related articles for article (PubMed ID: 9498941)

  • 41. A randomized, double-blind, double-dummy, safety crossover trial comparing cumulative doses up to 96 microg of formoterol delivered via an HFA-134a-propelled pMDI vs. same cumulative doses of formoterol DPI and placebo in asthmatic patients.
    Molimard M; Guenolé E; Duvauchelle T; Vicaut E; Lefrançois G
    Respiration; 2005; 72 Suppl 1():28-34. PubMed ID: 15915010
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Efficacy and safety profile of fluticasone furoate administered once daily in the morning or evening: a randomized, double-blind, double-dummy, placebo-controlled trial in adult and adolescent patients with persistent bronchial asthma.
    Medley H; Orozco S; Allen A
    Clin Ther; 2012 Aug; 34(8):1683-95. PubMed ID: 22796247
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Pharmacokinetics, Pharmacodynamics, Efficacy, and Safety of Albuterol (Salbuterol) Multi-dose Dry-Powder Inhaler and ProAir(®) Hydrofluoroalkane for the Treatment of Persistent Asthma: Results of Two Randomized Double-Blind Studies.
    Kerwin EM; Taveras H; Iverson H; Wayne D; Shah T; Lepore MS; Miller DS
    Clin Drug Investig; 2016 Jan; 36(1):55-65. PubMed ID: 26541599
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Efficacy, tolerability, and effect on asthma-related quality of life of formoterol bid via multidose dry powder inhaler and albuterol QID via metered dose inhaler in patients with persistent asthma: a multicenter, randomized, double-blind, double-dummy, placebo-controlled, parallel-group study.
    Busse W; Levine B; Andriano K; Lavecchia C; Yegen U
    Clin Ther; 2004 Oct; 26(10):1587-98. PubMed ID: 15598475
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Efficacy response of inhaled HFA-albuterol delivered via the breath-actuated Autohaler inhalation device is comparable to dose in patients with asthma.
    Gross G; Cohen RM; Guy H
    J Asthma; 2003; 40(5):487-95. PubMed ID: 14529098
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Efficacy and safety of fluticasone propionate hydrofluoroalkane inhalation aerosol in pre-school-age children with asthma: a randomized, double-blind, placebo-controlled study.
    Qaqundah PY; Sugerman RW; Ceruti E; Maspero JF; Kleha JF; Scott CA; Wu W; Mehta R; Crim C
    J Pediatr; 2006 Nov; 149(5):663-670. PubMed ID: 17095339
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Efficacy, safety, and impact on quality of life of salmeterol in patients with moderate persistent asthma.
    Busse WW; Casale TB; Murray JJ; Petrocella V; Cox F; Rickard K
    Am J Manag Care; 1998 Nov; 4(11):1579-87. PubMed ID: 10338904
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Efficacy and safety of fluticasone propionate/salmeterol HFA 134A MDI in patients with mild-to-moderate persistent asthma.
    Pearlman DS; Peden D; Condemi JJ; Weinstein S; White M; Baitinger L; Scott C; Ho SY; House K; Dorinsky P
    J Asthma; 2004; 41(8):797-806. PubMed ID: 15641629
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Effects on lung function, symptoms, and bronchial hyperreactivity of low-dose inhaled beclomethasone dipropionate given with HFA-134a or CFC propellant.
    Woodcock A; Williams A; Batty L; Masterson C; Rossetti A; Cantini L
    J Aerosol Med; 2002; 15(4):407-14. PubMed ID: 12581507
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Equivalent asthma control and systemic safety of inhaled budesonide delivered via HFA-134a or CFC propellant in a broad range of doses.
    Grzelewska-Rzymowska I; Malolepszy J; de Molina M; Sladek K; Zarkovice J; Siergiejko Z;
    Respir Med; 2003 Nov; 97 Suppl D():S10-9. PubMed ID: 14753247
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Efficacy and tolerability of salmeterol/fluticasone propionate versus montelukast in childhood asthma: A prospective, randomized, double-blind, double-dummy, parallel-group study.
    Maspero J; Guerra F; Cuevas F; Gutierrez JP; Soto-Ramos M; Anderton S; Mechali D; Chan R; Pedersen S
    Clin Ther; 2008 Aug; 30(8):1492-504. PubMed ID: 18803991
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Diskus and diskhaler: efficacy and safety of fluticasone propionate via two dry powder inhalers in subjects with mild-to-moderate persistent asthma.
    Galant SP; van Bavel J; Finn A; Gross G; Pleskow W; Brown A; Hamedani AG; Harding SM
    Ann Allergy Asthma Immunol; 1999 Mar; 82(3):273-80. PubMed ID: 10094218
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Protection against methacholine bronchoconstriction to assess relative potency of inhaled beta2-agonist.
    Parameswaran KN; Inman MD; Ekholm BP; Morris MM; Summers E; O'Byrne PM; Hargreave FE
    Am J Respir Crit Care Med; 1999 Jul; 160(1):354-7. PubMed ID: 10390425
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Salmeterol xinafoate in children on high dose inhaled steroids.
    Russell G; Williams DA; Weller P; Price JF
    Ann Allergy Asthma Immunol; 1995 Nov; 75(5):423-8. PubMed ID: 7583864
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Effect of Interval Between Actuations of Albuterol Hydrofluoroalkane Pressurized Metered-Dose Inhalers on Their Aerosol Characteristics.
    Berlinski A; Pennington D
    Respir Care; 2017 Sep; 62(9):1123-1130. PubMed ID: 28611228
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Efficacy and safety of beclomethasone dipropionate extrafine aerosol in childhood asthma: a 12-week, randomized, double-blind, placebo-controlled study.
    Nayak A; Lanier R; Weinstein S; Stampone P; Welch M
    Chest; 2002 Dec; 122(6):1956-65. PubMed ID: 12475833
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Efficacy and safety of salmeterol/fluticasone propionate delivered via a hydrofluoroalkane metered dose inhaler in Chinese patients with moderate asthma poorly controlled with inhaled corticosteroids.
    You-Ning L; Humphries M; Du X; Wang L; Jiang J
    Int J Clin Pract; 2005 Jul; 59(7):754-9. PubMed ID: 15963199
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Maintaining asthma control in persistent asthma: comparison of three strategies in a 6-month double-blind randomised study.
    Godard P; Greillier P; Pigearias B; Nachbaur G; Desfougeres JL; Attali V
    Respir Med; 2008 Aug; 102(8):1124-31. PubMed ID: 18606533
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Efficacy of chlorofluorocarbon-free beclomethasone dipropionate 400 micrograms day-1 delivered as an extrafine aerosol in adults with moderate asthma.
    Matthys H; Nowak D; Hader S; Kunkel G
    Respir Med; 1998 Jun; 92 Suppl A():17-22. PubMed ID: 9850359
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Bronchial asthma treated with long-acting beta 2 agonist. Comparison between formoterol (12 mu/g) inhaled twice daily and salbutamol (200 mu/g) inhaled 4 times daily].
    Sprogøe-Jakobsen U; Viktrup L; Davidsen O; Viskum K
    Ugeskr Laeger; 1992 Nov; 154(47):3325-8. PubMed ID: 1361083
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.